SCHEMBL4933091

SCHEMBL4933091

Cn1ccc(-c2cc(C(=O)N3CCOCC3)nn2-c2cccnc2)c1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.57
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPT P10636 3/20 0.53
PTGS2 P35354 11/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
SMPD1 P17405 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266925 0.86 MEN1 (0.56) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4932850 0.86 MGLL (0.44) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4932636 0.85 MGLL (0.53) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4924669 0.85 MGLL (0.44) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4927977 0.83 MARS1 (0.58) MEN1KMT2ASMN1; SMN2
SCHEMBL5269492 0.82 MEN1 (0.53) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4927321 0.81 MGLL (0.56) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4929746 0.80 MGLL (0.51) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4932389 0.78 MGLL (0.49) MGLLMEN1KMT2AMAPTPTGS2
SCHEMBL4930153 0.78 KMT2A (0.53) MGLLMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064682-A1 Pyrazole Derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-03-13 US disclosed
US-20080064682-A1 Pyrazole Derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-03-13 US disclosed
US-20080064682-A1 Pyrazole Derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-03-13 US disclosed
EP-1762568-A1 PYRAZOLE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-14 EP disclosed
EP-1762568-A1 PYRAZOLE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064682-A1 Pyrazole Derivatives NAT1, AR, CBR3 MGLL 4785/4885MEN1 3847/4885KMT2A 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.